DSE

gene product
DS-Epi1, DSEPI, SART2
The protein encoded by this gene is a tumor-rejection antigen. It is localized to the endoplasmic reticulum and functions to convert D-glucuronic acid to L-iduronic acid during the biosynthesis of dermatan sulfate. This antigen possesses tumor epitopes capable of inducing HLA-A24-restricted and tumor-specific cytotoxic T lymphocytes in cancer patients and may be useful for specific immunotherapy. Mutations in this gene cause inmusculocontractural Ehlers-Danlos syndrome. Alternative splicing results in multiple transcript variants. A related pseudogene has been identified on chromosome 9, and a paralogous gene exists on chromosome 18. [provided by RefSeq, Apr 2016]
More gene data

Featured antibodies

Antibodies

 

Filters

Application

Antibodypedia Validation Initiative

Validation method

Reference

Provider

Host

Reactivity

Antibody type

Conjugate

Antibody

  or   Clear
Enhanced validation
Enhanced validation
Supportive data in Antibodypedia
Data presented on provider website
Data in Antibodypedia (inconclusive)
Validated within AVI
Eligible for validation within AVI
76 antibodies from 18 providers.

Antibody properties

General

Applications

or Cancel
Antibody
antibodies-online
26 antibodies
Proteintech Group
2 antibodies
Invitrogen Antibodies
2 antibodies
NovoPro Bioscience Inc.
2 antibodies
Novus Biologicals
3 antibodies
Abnova Corporation
5 antibodies
Atlas Antibodies
2 antibodies
Biorbyt
11 antibodies
Abgent
1 antibody
LifeSpan BioSciences, Inc.
9 antibodies
RabMAbs
1 antibody
Affinity Biosciences
1 antibody
GeneTex
1 antibody
Creative Biolabs
3 antibodies
Sigma-Aldrich
2 antibodies
Abbexa
3 antibodies
Leading Biology
1 antibody
United States Biological
1 antibody